IKZF1 and acute lymphoblastic leukemia: Approximately 15%–20% of children diagnosed with B‐cell precursor ALL (BCP‐ALL) show deletions in IKZF1; this figure increases to ~70% in Philadelphia‐chromosome‐positive (Ph+) and ~40% in Ph‐like‐chromosome‐positive individuals (Boer et al., 2016).